Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Issue 6 (25th November 2020)

• Record Type: Journal Article
• Authors: Hantel, Andrew; DuMontier, Clark; Odejide, Oreofe O.; Luskin, Marlise R.; Sperling, Adam S.; Hshieh, Tammy; Chen, Richard; Soiffer, Robert; Driver, Jane A.; Abel, Gregory A.
• Is Part Of: Cancer. Volume 127:Issue 6(2021)
• Page Start: 875
• Page End: 883
• Publication Date: 2020-11-25
• Subjects: frailty -- gait speed -- geriatric oncology -- hematologic malignancy; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.33344
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : Background: Brief measures of physical function such as gait speed may be useful to optimize treatment intensity for older adults who have blood cancer; however, little is known about whether such assessments are already captured within oncologists' "gestalt" assessments. Methods: Gait speed was assessed in 782 patients ≥75 years of age who had blood cancer, with results reported to providers after treatment decisions were made; 408 patients required treatment when different intensities were available per National Comprehensive Cancer Network (NCCN) guidelines. We performed structured abstractions of treatment intensity recommendations into standard intensity, reduced intensity, or supportive care, based on NCCN guidelines. We modeled gait speed and survival using Cox regression and performed ordinal logistic regression to assess predictors of NCCN‐based categorizations of oncologists' treatment intensity recommendations, including gait speed. Results: The median survival by gait speed category was 10.8 months (<0.4 m/s), 18.6 months (0.4‐0.6 m/s), 34.0 months (0.6‐0.8 m/s), and unreached (>0.8 m/s). Univariable hazard ratios (HRs) for death increased for each lower category compared with ≥0.8 m/s (0.6‐0.8 m/s: HR, 1.76; 0.4‐0.6 m/s: HR, 2.30; <0.4 m/s: HR, 3.31). Gait speed predicted survival in multivariable Cox regression (all P < .05). In multivariable models including age, sex, and Eastern Cooperative Oncology Group performance status, gait speed did not predict oncologists' recommended treatment intensity (all P > .05) and did not add to a base model predicting recommended treatment intensity. Conclusion: In older adults with blood cancer who presented for treatment, gait speed predicted survival but not treatment intensity recommendation. Incorporating gait speed into decision making may improve optimal treatment selection. Abstract : Gait speed predicts survival but not the intensity of recommended treatment in older adults with blood cancer. Incorporating gait speed into decision‐making may improve treatment selection.